RxDoctor Payments Data

Nancy Newman, MD

Neuro-ophthalmology · Atlanta, GANPI 1902863707

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,330 of the $48,172 with a category attached, or 73.3%. Chiesi USA, Inc. accounts for 94.0% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $19,987, more than ten times the $1,253 reported in 2019.

$48,172in general payments, 2019–2025

Across 32 payments — averaging $1505.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$45K
  • Biogen$2K
  • Topcon Healthcare, Inc.$534
  • Alcon$104

What the payments were for

  • Consulting fees$35,33073%
  • Speaking & faculty fees$2,6255%
  • Travel & lodging$9,30319%
  • Food & beverage$9142%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Chiesi USA, Inc.24$45,281
Biogen2$2,253
Topcon Healthcare, Inc.5$534
Alcon1$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neuro-ophthalmology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$20,892
Medicare patients
56
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuro-ophthalmology in Atlanta

Where these figures come from

Is this you, or does something look wrong? →